Drug and supplement recalls

A no-JavaScript view of recent drug and supplement recalls in the latest Recall Radar snapshot. For the compact cross-category view, use the snapshot summary. To compare product, firm, code, and reason clues, use the private match checker, product clue index, code clue index, reason clue index, or search starter links. For all loaded records, use the latest recall digest, the newly reported recalls page, the report-date index, the source status page, the nationwide recalls page, the location clue index, the highest concern page, the ongoing recalls page, the recall action checklist, the recall field guide, or interactive Recall Radar Drugs filter.

GeneratedSep 7, 2026, 6:36 PM EDT
Loaded12
Class I0
Ongoing12
Class II Ongoing Reported Sep 2, 2026

Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx only, Manufactured for: Exelan Pharmaceuticals, Inc....

Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).

Nationwide within the United States

Firm
Hikma Pharmaceuticals USA INC.
Recall began
Aug 24, 2026
Quantity
a) 25,970 bottles; b) 2,384 bottles
Codes
a) Lot #: AC5470A, Exp. Date July 2027 b) Lot #: AC5470B, Exp. Date July 2027
FDA IDs
D-0831-2026 / event 99711
Source
openFDA source record
Class II Ongoing Reported Sep 2, 2026

Zicam, Cold Remedy, Medicated Nasal Swabs, With Cooling Menthol & Eucalyptus, 20 Single-Use Swabs per carton, Zinc-Free Homeopathic, Distributed by Church & Dwight Co. Inc., Ewing,...

CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing

US Nationwide.

Firm
Church & Dwight Co., Inc.
Recall began
Aug 10, 2026
Quantity
318,600 cartons
Codes
Lot # UN52882, Exp Date: 04/30/2028; Lot # UN53431, Exp Date: 06/30/2028; Lot # UN60411, Exp Date: 08/31/2028.
FDA IDs
D-0790-2026 / event 99604
Source
openFDA source record
Class II Ongoing Reported Sep 2, 2026

Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceutic...

Subpotent Drug

Nationwide within the United States

Firm
ACCORD HEALTHCARE, INC.
Recall began
Aug 6, 2026
Quantity
N/A
Codes
Lot #: D2401927, D2401833, Exp. Date 08/31/2026; D2402551, D2402552, Exp. Date 11/30/2026; D2500220, Exp. Date 12/31/2026; D2500223, Exp. Date 01/31/2027.
FDA IDs
D-0775-2026 / event 99584
Source
openFDA source record
Class II Ongoing Reported Sep 2, 2026

Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceutica...

Subpotent Drug

Nationwide within the United States

Firm
ACCORD HEALTHCARE, INC.
Recall began
Aug 6, 2026
Quantity
N/A
Codes
Lot #: D2401834, D2401982, Exp. Date 08/31/2026; D2402584, D2402585, D2402586, D2402588, D2402587, D2402589, Exp Date. 11/30/2026.
FDA IDs
D-0776-2026 / event 99584
Source
openFDA source record
Class II Ongoing Reported Sep 2, 2026

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceutic...

Subpotent Drug

Nationwide within the United States

Firm
ACCORD HEALTHCARE, INC.
Recall began
Aug 6, 2026
Quantity
N/A
Codes
Lot #: D2402016, D2402017, Exp. Date 08/31/2026
FDA IDs
D-0777-2026 / event 99584
Source
openFDA source record
Class II Ongoing Reported Sep 2, 2026

Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuti...

Subpotent Drug

Nationwide within the United States

Firm
ACCORD HEALTHCARE, INC.
Recall began
Aug 6, 2026
Quantity
N/A
Codes
Lot #: D2401983, Exp. Date 08/31/2026; D2402640, D2402641, Exp. Date 11/30/2026; D2500224, Exp. Date 01/31/2027.
FDA IDs
D-0781-2026 / event 99584
Source
openFDA source record
Class II Ongoing Reported Sep 2, 2026

Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count bottles (NDC 16729-454-15) b) 1000-count bottles (NDC 16729-454-17), Rx Only, Manufactured for: Accor...

Subpotent Drug

Nationwide within the United States

Firm
ACCORD HEALTHCARE, INC.
Recall began
Aug 6, 2026
Quantity
N/A
Codes
a) Lot # D2402125, D2402126, D2402127, Exp. Date 09/30/2026. b) Lot #: D2402523, D2402524, Exp. Date 11/30/2026.
FDA IDs
D-0782-2026 / event 99584
Source
openFDA source record
Class II Ongoing Reported Sep 2, 2026

Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceutic...

Subpotent Drug

Nationwide within the United States

Firm
ACCORD HEALTHCARE, INC.
Recall began
Aug 6, 2026
Quantity
N/A
Codes
Lot #: D2402195, D2402196, D2402197, Exp. Date 09/30/2026.
FDA IDs
D-0783-2026 / event 99584
Source
openFDA source record
Class II Ongoing Reported Sep 2, 2026

Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, Manufactured for: Acc...

Subpotent Drug

Nationwide within the United States

Firm
ACCORD HEALTHCARE, INC.
Recall began
Aug 6, 2026
Quantity
N/A
Codes
a) Lot # D2402430, D2402431, Exp Date: 10/31/2026. b) Lot #: D2402432, Exp. Date 10/31/2026; D2500180, Exp. Date 12/31/2026.
FDA IDs
D-0785-2026 / event 99584
Source
openFDA source record
Class II Ongoing Reported Sep 2, 2026

Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals...

Subpotent Drug

Nationwide within the United States

Firm
ACCORD HEALTHCARE, INC.
Recall began
Aug 6, 2026
Quantity
N/A
Codes
Lot #: D2402337, Exp. Date 10/31/2026.
FDA IDs
D-0786-2026 / event 99584
Source
openFDA source record
Class II Ongoing Reported Sep 2, 2026

Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2

Presence of particulate matter: glass and stopper piece

USA Nationwide

Firm
Mallinckrodt Hospital Products Inc.
Recall began
Aug 6, 2026
Quantity
12367 vials
Codes
Lot#: NDC 63004-8710-1 - 1564-107, exp 1/31/2027 NDC 63004-8710-2 - 1564-107H, exp 1/31/2027
FDA IDs
D-0803-2026 / event 99570
Source
openFDA source record
Class II Ongoing Reported Sep 2, 2026

Clobetasol Propionate Cream USP, 0.05%, 60 g tube, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Pithampu...

Failed content uniformity specifications.

USA Nationwide

Firm
Lupin Pharmaceuticals Inc.
Recall began
Aug 3, 2026
Quantity
5082 tubes
Codes
Lot#: KB00427, Exp date 4/30/2028; KA00308, Exp date 10/31/2026
FDA IDs
D-0789-2026 / event 99544
Source
openFDA source record